These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 558624)

  • 1. Caffeine potentiation of amphetamine: implications for hyperkinesis therapy.
    Schechter MD
    Pharmacol Biochem Behav; 1977 Mar; 6(3):359-61. PubMed ID: 558624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine and caffeine on schedule-controlled and schedule-induced responding.
    McMillan DE
    J Exp Anal Behav; 1979 Nov; 32(3):445-56. PubMed ID: 512573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats.
    Harland RD; Gauvin DV; Michaelis RC; Carney JM; Seale TW; Holloway FA
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1017-23. PubMed ID: 2798526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine discrimination in the rat.
    Modrow HE; Holloway FA; Carney JM
    Pharmacol Biochem Behav; 1981 May; 14(5):683-8. PubMed ID: 6787618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine potentiation of apomorphine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Aug; 13(2):307-9. PubMed ID: 6251484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers.
    Chait LD; Johanson CE
    Psychopharmacology (Berl); 1988; 96(3):302-8. PubMed ID: 3146764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO; Dekirmenjian H; Chapel JL
    Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cocaine and d-amphetamine toxicity with caffeine.
    Derlet RW; Tseng JC; Albertson TE
    Am J Emerg Med; 1992 May; 10(3):211-6. PubMed ID: 1586430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 10. Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue.
    Holloway FA; Michaelis RC; Huerta PL
    Life Sci; 1985 Feb; 36(8):723-30. PubMed ID: 3974408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects.
    Young R; Gabryszuk M; Glennon RA
    Pharmacol Biochem Behav; 1998 Oct; 61(2):169-73. PubMed ID: 9738532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine-induced stimulus control.
    Winter JC
    Pharmacol Biochem Behav; 1981 Aug; 15(2):157-9. PubMed ID: 7312889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of behavioral effects of cathinone, amphetamine and apomorphine.
    Schechter MD; Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1984 Feb; 20(2):181-4. PubMed ID: 6718445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Alternating caffeine and stimulants.
    Fras I
    Am J Psychiatry; 1974 Feb; 131(2):228-9. PubMed ID: 4809054
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting amphetamine response in hyperkinetic children by electronic pupillography.
    Knopp W; Arnold LE; Andras RL; Smeltzer DJ
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):158-66. PubMed ID: 4795017
    [No Abstract]   [Full Text] [Related]  

  • 16. Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity.
    White BC; Keller GE
    Pharmacol Biochem Behav; 1984 Mar; 20(3):383-6. PubMed ID: 6709673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dopamine in d-amphetamine-induced discriminative responding.
    Ho BT; Huang JT
    Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Jan; 272(1):100-11. PubMed ID: 7815322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms.
    Arnold LE; Wender PH; McCloskey K; Snyder SH
    Arch Gen Psychiatry; 1972 Dec; 27(6):816-22. PubMed ID: 4564954
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone, prolactin and cortisol responses and growth patterns in hyperkinetic children treated with dextro-amphetamine. Preliminary findings.
    Puig-Antich J; Greenhill LL; Sassin J; Sachar EJ
    J Am Acad Child Psychiatry; 1978; 17(3):457-75. PubMed ID: 690355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.